Success Metrics

Clinical Success Rate
97.4%

Based on 37 completed trials

Completion Rate
97%(37/38)
Active Trials
5(11%)
Results Posted
35%(13 trials)
Terminated
1(2%)

Phase Distribution

Ph phase_2
8
17%
Ph phase_3
2
4%
Ph phase_4
4
9%
Ph phase_1
1
2%
Ph not_applicable
30
65%

Phase Distribution

1

Early Stage

8

Mid Stage

6

Late Stage

Phase Distribution45 total trials
Phase 1Safety & dosage
1(2.2%)
Phase 2Efficacy & side effects
8(17.8%)
Phase 3Large-scale testing
2(4.4%)
Phase 4Post-market surveillance
4(8.9%)
N/ANon-phased studies
30(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.9%

37 of 39 finished

Non-Completion Rate

5.1%

2 ended early

Currently Active

5

trials recruiting

Total Trials

46

all time

Status Distribution
Active(5)
Completed(37)
Terminated(2)
Other(2)

Detailed Status

Completed37
Recruiting4
unknown2
Terminated1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
46
Active
5
Success Rate
97.4%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (2.2%)
Phase 28 (17.8%)
Phase 32 (4.4%)
Phase 44 (8.9%)
N/A30 (66.7%)

Trials by Status

terminated12%
withdrawn12%
active_not_recruiting12%
completed3780%
unknown24%
recruiting49%

Recent Activity

5 active trials
Showing 5 of 46
completedphase_2

Exenatide for Smoking Cessation and Prevention of Weight Gain

NCT05610800
recruitingnot_applicable

Wellness Intervention for Smoking and HIV

NCT04725617
recruitingnot_applicable

FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

NCT05429892
active_not_recruitingnot_applicable

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

NCT04236791
recruitingnot_applicable

Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation

NCT06931054
View all 46 trials

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT05610800Phase 2

Exenatide for Smoking Cessation and Prevention of Weight Gain

Completed
NCT04725617Not Applicable

Wellness Intervention for Smoking and HIV

Recruiting
NCT05429892Not Applicable

FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

Recruiting
NCT04236791Not Applicable

The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an Aid for Smoking Cessation-extension of Follow-up

Active Not Recruiting
NCT06931054Not Applicable

Combination of Acupuncture, Auricular Acupressure and Nicotine Replacement Therapy for Smoking Cessation

Recruiting
NCT04725656Not Applicable

Concentration Impact Nicotine Salt

Recruiting
NCT03612375Not Applicable

ESTxENDS Trial-Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in Urine

Completed
NCT03603353Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Sleep Quality.

Completed
NCT04617444Not Applicable

The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function

Completed
NCT03612453Not Applicable

ESTxENDS Trial- Substudy on Oxidative Stress Induced by Electronic Nicotine Delivery Systems (ENDS) Measured in EBC

Completed
NCT03612336Not Applicable

The ESTxENDS Trial- Substudy on the Metabolic Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03632421Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on Respiratory Symptoms

Completed
NCT03603340Not Applicable

The ESTxENDS Trial- Substudy on the Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Depression

Completed
NCT04244773Not Applicable

ESTxENDS Trial: MN Substudy - Micronuclei in Buccal Epithelium, a Surrogate Measure of Future Cancer Risk, Induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03612544Not Applicable

The ESTxENDS Trial- Substudy on the Effect on Toxins From Using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig)

Completed
NCT03938298Not Applicable

The ESTxENDS Trial: Pulmonary Function Substudy

Completed
NCT01413516Phase 2

Varenicline In-Patient Study

Completed
NCT03712098Phase 2

Daily Liraglutide for Nicotine Dependence

Completed
NCT04928781Not Applicable

Smoking Cessation Study

Withdrawn
NCT03087617Not Applicable

Personalized Smoking Cessation Tool Based on Patient Lung CT Image

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
46